Table 1. PBMC cytolytic activity (NK cell activity) induced by FPP administration for 30 days*.
| PBMC cytolytic activity [10:1 (8.9–29.5), 20:1 (17.1–48.7)] | IgG (820–1740) | IgA (90–400) | IgM [♂(31–200), ♀(52–270)] | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| before | after | P value | before | After | P | before | after | P | before | After | P | |
| 9 g/day | 2017±682 | 2119±827 ±±827 | 0.19 | 360±82 | 364±103 | 0.73 | 123±100 | 120±86 | 0.69 | |||
| E:T = 10:1 | 2.9±1.1 | 25.0±16.6 | 0.035 | |||||||||
| E:T = 20:1 | 24.2±22.6 | 30.6±25.1 | 0.126 | |||||||||
| 3 g/day | 1731±506 | 1697±512 | 0.30 | 454±189 | 436±196 | 0.09 | 106±67 | 101±60 | 0.07 | |||
| E:T = 10:1 | 2.2±0.7 | 14.4±12.7 | 0.045 | |||||||||
| E:T = 20:1 | 11.6±8.3 | 23.0±17.3 | 0.036 | |||||||||
| Control | No FPP | for 30 days | 1551±198 | 1533±280 | 0.81 | 500±197 | 506±207 | 0.81 | 74±9 | 64±12 | 0.01 | |
| E:T = 10:1 | 2.7±0.9 | 7.4±4.9 | 0.088 | |||||||||
| E:T = 20:1 | 10.0±7.1 | 13.8±7.9 | 0.256 | |||||||||
*Data in parentheses are normal values for 20–65-year-old healthy subjects.